Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Thoracic Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer John R. Adler
 Brain Cancer
Neoplasm Metastasis
Lung Cancer
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-Line Treatment for (Stage IIIb/IV) Non-Small Cell Lung Cancer (ATTRACT-2) Heather A. Wakelee
 Lung Cancer
An Observational Study of the Ethnic Impact of Patients Undergoing 2nd Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed Heather A. Wakelee
 Lung Cancer
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Heather A. Wakelee
 Lung Cancer
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer Harlan Pinto
 Lung Cancer
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without a Biological Inhibitor in Treating Patients with Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Dr. Billy W. Loo Jr. M.D. Ph.D.
 Lung Cancer
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Normal Estradiol Heather A. Wakelee
 Lung Cancer
A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer Heather A. Wakelee
 Carcinoma, Non-Small-Cell Lung
AZD0530 in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer Heather A. Wakelee
 Thymoma
Thymus Neoplasms
A Phase 1/2 Study of Aflibercept Administered in Combination with Pemetrexed and Cisplatin in Patients with Advanced Carcinoma Heather A. Wakelee
 Carcinoma, Non-Small-Cell Lung


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors Paul J Keall
Amit Sawant
 Pancreatic Cancer
Liver Cancer
Lung Cancer
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Joseph B. Shrager
 Lung Cancer
Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors George Albert Fisher M.D. Ph.D.
Russell Pachynski
 Head and Neck Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Colonic Neoplasms
Lung Cancer
Colon Cancer
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma Glenn D. Rosen
Daya Upadhyay
 Carcinoma, Giant Cell
Carcinoma, Non-Small-Cell Lung
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients Heather A. Wakelee
 Lung Cancer
Identification of Secreted Markers for Tumor Hypoxia in Patients with Head and Neck or Lung Cancers Quynh-Thu Le
 Head and Neck Cancer
Lip Neoplasms
Lip Cancer
Lung Cancer
18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases Sanjiv Sam Gambhir M.D., Ph.D.
 Breast Cancer
Prostatic Neoplasms
Bone Cancer
Lung Cancer
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery Dr. Billy W. Loo Jr. M.D. Ph.D.
 Lung Cancer
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Dr. Billy W. Loo Jr. M.D. Ph.D.
 Lung Cancer
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy for NSCLC Joseph B. Shrager
 Carcinoma, Non-Small-Cell Lung

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
(Completed) 		Heather A. Wakelee
 Carcinoma, Small Cell
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
(No longer recruiting) 		Harlan Pinto
 Lung Cancer
Phase II trial of bevacizumab in combination with pemetrexed as 2nd line therapy in patients with stable brain metastases from non-small cell lung cancer
(No longer recruiting) 		Heather A. Wakelee
 Neoplasm Metastasis
Lung Cancer
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (excluding squamous cell)
(No longer recruiting) 		Heather A. Wakelee
 Lung Cancer
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
(No longer recruiting) 		Dr. Billy W. Loo Jr. M.D. Ph.D.
 Lung Cancer
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
(No longer recruiting) 		Quynh-Thu Le
 Lung Cancer
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
(No longer recruiting) 		Heather A. Wakelee
 Lung Cancer
PR-104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
(No longer recruiting) 		Dr. A. Dimitrios Colevas
 Lung Cancer
A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
(No longer recruiting) 		Heather A. Wakelee
 Carcinoma, Non-Small-Cell Lung
Lung Diseases
Carcinomas (including Squamous Cell and Adenocarcinoma)
Thoracic Neoplasms
Neoplasms, Glandular and Epithelial
Lung Cancer
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
(No longer recruiting) 		Heather A. Wakelee
 Carcinoma, Non-Small-Cell Lung


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: